Biotech Boom: Stocks Surge on New Drug Approvals
Wall Street is buzzing with excitement as biotech stocks leapfrog in response to a wave of recent drug authorizations. Investors are injecting money into the sector, driven by the promise of these revolutionary therapies that address complex diseases. The pharmaceutical industry is on the cusp of a golden age, and investors are eager to be part of